首页> 外文期刊>The European Journal of Psychiatry (Spanish Edition) >Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder

【24h】

Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder

机译：在长期和安慰剂对照的随机戒断研究中，盐酸阿托莫西汀的安全性和耐受性在欧洲和非欧洲有注意缺陷/多动障碍的成年人中进行

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The European Journal of Psychiatry (Spanish Edition)》 |2013年第3期|共页
作者
Allen Albert J; Camporeale Angelo; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) Barcelona Spain; Escobar Rodrigo; Hospital Universitari Vall dHebron; inVentiv Health Clinical Indianapolis USA; Lane Jeannine R.; Lilly Corporate Center Indianapolis USA; Ramos-Quiroga J. Antoni; Tanaka Yoko; Trzepacz Paula; Universitat Autònoma de Barcelona Bellaterra Spain; Upadhyaya Himanshu; Williams David;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and Non-European adults with attention-deficit/ hyperactivity disorder [J] . CamporealeA., UpadhyayaH., Ramos-QuirogaJ.A., The European journal of psychiatry . 2013,第3期

机译：在长期和安慰剂对照的随机戒断研究中，盐酸阿托莫西汀的安全性和耐受性在欧洲和非欧洲有注意力缺陷/多动障碍的成年人中进行
2. Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder [J] . Camporeale Angelo, Upadhyaya Himanshu, Ramos-Quiroga J. Antoni, The European journal of psychiatry. . 2013,第3期

机译：在长期和安慰剂对照的随机戒断研究中，盐酸阿托莫西汀的安全性和耐受性在欧洲和非欧洲有注意缺陷/多动障碍的成年人中进行
3. Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: A placebo-controlled, randomised withdrawal study [J] . UpadhyayaH., Ramos-QuirogaJ.A., AdlerL.A., The European journal of psychiatry . 2013,第3期

机译：在欧洲和非欧洲有注意力缺陷/多动障碍的成人门诊患者中，使用盐酸阿托西汀开放标签治疗后维持应答：一项安慰剂对照，随机停药研究
4. Analysis of Resting State EEG Signals of Adults with Attention-Deficit Hyperactivity Disorder [C] . Simranjit Kaur, Sukhwinder Singh, Priti Arun, International Doctoral Symposium on Applied Computation and Security Systems . 2019

机译：具有注意力缺陷多动障碍的成人静态状态脑电图信号分析
5. Use of attention deficit/hyperactivity disorder pharmacological treatment following the public discussion on cardiovascular safety and the introduction of medication guides for central nervous system stimulants and atomoxetine. [D] . Chen, Chih-Ying. 2010

机译：在对心血管安全进行公开讨论并引入中枢神经系统兴奋剂和阿托西汀的用药指南后，使用注意缺陷/多动障碍药物治疗。
6. Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled randomized treatment study with atomoxetine [O] . Himanshu Upadhyaya, Lenard A Adler, Miguel Casas, 2013

机译：参加阿托西汀的安慰剂对照随机治疗研究的欧洲和非欧洲成年注意力不足过动症成人患者的基线特征
7. Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder [O] . Angelo Camporeale, Himanshu Upadhyaya, J. Antoni Ramos-Quiroga, 2013

机译：欧洲和非欧洲成年人的长期盐酸盐酸盐酸盐盐酸盐的安全性和耐受性，具有关注缺陷/多动障碍

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号